JONES WILLIAM A JR Insider Trades

Insider Trading History

Track insider trading activity for JONES WILLIAM A JR. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Annexon
Annexon ANNX
Director
Holding Value $423k 65,000 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$306k 65,000 shares
$4.70
$6.50
Apogee Therapeutics
Apogee Therapeutics APGE
Director
Holding Value $1.03M 7,657 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$651k 7,657 shares
$85.00
$133.96
Apogee Therapeutics
Apogee Therapeutics APGE
Director
Holding Value $1.94M 14,461 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$602k 14,461 shares
$41.66
$133.96
Annexon
Annexon ANNX
Director
Holding Value $358k 55,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 55,000 shares
$2.55
$6.50
Annexon
Annexon ANNX
Director
Holding Value $572k 88,000 shares
Last Trade
Jan 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$425k 88,000 shares
$4.83
$6.50
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Commercial Officer
Holding Value $1.07M 43,000 shares
Last Trade
Jan 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$636k 43,000 shares
$14.78
$24.89
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Commercial Officer
Holding Value $1.43M 43,000 shares
Last Trade
Jan 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12M 43,000 shares
$26.04
$33.29
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Commercial Officer
Holding Value $6.66M 200,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.19M 200,000 shares
$25.96
$33.29
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Commercial Officer
Holding Value $4.98M 200,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 200,000 shares
$14.39
$24.89
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) NAMSW
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Apr 25, 2024 Sale
$9.11M 945,598 shares
$9.63
$24.89
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV NAMS
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Apr 25, 2024 Sale
$20.3M 945,598 shares
$21.44
$33.29
Akili
Akili AKLI
Director
Holding Value $9.53k 22,000 shares
Last Trade
May 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24k 22,000 shares
$1.09
$0.43
Akili
Akili AKLI
Director
Holding Value $19.1k 44,000 shares
Last Trade
Nov 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$101k 44,000 shares
$2.30
$0.43
Biohaven
Biohaven BHVN
Director, Cco-migraine & Common Disease
Holding Value $0 0 shares
Last Trade
Oct 03, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$455k 3,000 shares
$151.80
$14.86
Biohaven
Biohaven BHVN
Cco-migraine & Common Disease
Holding Value $167k 11,250 shares
Last Trade
Jan 07, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$483k 3,750 shares
$128.87
$14.86
Biohaven
Biohaven BHVN
Cco-migraine & Common Disease
Holding Value $446k 30,000 shares
Last Trade
Jan 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.87M 30,000 shares
$128.87
$14.86
Biohaven
Biohaven BHVN
Cco-migraine & Common Disease
Holding Value $208k 13,999 shares
Last Trade
Jan 07, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$210k 1,631 shares
$128.87
$14.86
Biohaven
Biohaven BHVN
Cco-migraine & Common Disease
Holding Value $223k 15,000 shares
Last Trade
Jan 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.93M 15,000 shares
$128.87
$14.86
Biohaven
Biohaven BHVN
Cco-migraine & Common Disease
Holding Value $232k 15,630 shares
Last Trade
Jan 07, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$483k 3,750 shares
$128.87
$14.86
Biohaven
Biohaven BHVN
Cco-migraine & Common Disease
Holding Value $149k 10,000 shares
Last Trade
Jan 06, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$656k 5,000 shares
$131.10
$14.86

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up